Esophageal Squamous Cell Carcinoma Clinical Trials in Shijiazhuang, Hebei
2 recruitingShijiazhuang, Hebei, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma (ESCC)
Hebei Medical University Fourth Hospital25 enrolled1 locationNCT07290010
Recruiting
Phase 2
Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital202 enrolled1 locationNCT03964753